James E. Flynn - Possible Members of 10% Group, 10%+ Owner at Oncology Institute, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Possible Members of 10% Group, 10%+ Owner
Stock Symbol
TOI, TOIIW on Nasdaq, DFPH on OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James E. Flynn since 11/27/2024

Holdings reported by James E. Flynn for Oncology Institute, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 1.61M $9.63M $6.00 Nov 12, 2021 Through Deerfield Partners, L.P.
Class A Common Stock 1.61M $9.63M $6.00 Nov 12, 2021 Through Deerfield Private Design Fund IV, L.P.
Class A Common Stock 85.1K $511K $6.00 Nov 12, 2021 Through Deerfield Management Company, L.P.
Class A Common Stock 40 $240 $6.00 Nov 12, 2021 Through DFP Sponsor, LLC
Private Placement Warrants 3.18M Nov 12, 2021 Through DFP Sponsor, LLC Class A Common Stock
Public Warrants 625K Nov 12, 2021 Through Deerfield Partners, L.P. Class A Common Stock
Public Warrants 625K Nov 12, 2021 Through Deerfield Private Design Fund IV, L.P. Class A Common Stock
Series A Common Stock Equivalent Convertible Preferred Stock 58.9K Nov 12, 2021 Through Deerfield Partners, L.P. Class A Common Stock
Series A Common Stock Equivalent Convertible Preferred Stock 58.9K Nov 12, 2021 Through Deerfield Private Design Fund IV, L.P. Class A Common Stock
Series A Common Stock Equivalent Convertible Preferred Stock 45.6K Nov 12, 2021 Through DFP Sponsor, LLC Class A Common Stock 4.56M
Class B Common Stock 0 Nov 12, 2021 Through Deerfield Management Company, L.P. Class A Common Stock
Class B Common Stock 0 Nov 12, 2021 Through DFP Sponsor, LLC Class A Common Stock

Transactions reported by James E. Flynn for Oncology Institute, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.